287 results on '"Jandrot-Perrus M"'
Search Results
2. PB0364 Glycoprotein VI-Targeted Antiplatelet Therapy with Glenzocimab is Safe in Patients Exposed to Current Antithrombotic and Fibrinolytic Drugs
3. OC 10.3 Platelets Mediate Intracranial Aneurysm Formation and Rupture in Mice
4. Crystal structure of the GPVI-glenzocimab complex
5. A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).
6. The future of glycoprotein VI as an antithrombotic target
7. An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis
8. Protective role of Protease Nexin-1 against lung fibrosis in bleomycin-treated mice: OR422
9. GPVI interaction with polymerized fibrin boosts thrombin generation and thrombus growth: OR420
10. Dual action of platelets and glycoprotein-VI in immune complex-mediated inflammation: OR170
11. Monocytes downregulate the early stage of collagen-induced platelet activation by a PECAM-1-dependent mechanism
12. GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy
13. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression
14. Characterization of losartan effects on platelets: PB 4.26–4
15. Variability in clinical and biological manifestations of anti-GPVI autoantibodies: about four new patients: PB 3.25–1
16. Characterization of the effects of losartan on human platelets: PB 3.23–6
17. Microparticles do not modify the antithrombotic properties of brain microvascular cells: PB 2.30–4
18. Resistance to aspirin in myeloproliferative neoplasms: is it a reality? Evaluation of low dose aspirin resistance in a pilot study including 54 patients: PB 1.27–1
19. Platelets limit the histotoxic activities of infiltrating neutrophils and act as vascular healing patches in inflamed tissues: PA 4.03–2
20. Hemostasis and thrombosis in JAK2V617F-KI mice: PA 1.03–3
21. Hemostasis and thrombosis in JAK2V617F-KI mice: OC 58.5
22. Endothelial Protease Nexin-1 potentiates the cytoprotective effects of activated Protein C by preventing endothelial Protein C receptor shedding: OC 54.5
23. Protease Nexin-1 regulates the retinal vascular development: OC 01.6
24. The serpin protease nexin‐1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin
25. Platelet glycoprotein VI deficiencies: No.17
26. Protease nexin-1 is anti-angiogenic in vitro independently of its anti-protease activity: OC-WE-070
27. Antithrombotic and antifibrinolytic effects of platelet protease nexin-1: AS-TU-024
28. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments
29. Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP
30. Rôle des neutrophil extracellular traps (NETs) dans la maladie de Behçet
31. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
32. A new macromolecular paramagnetic MR contrast agent binds to activated human platelets
33. Des fonctions plaquettaires aux implications thérapeutiques
34. Thrombin reduces MuSK and acetylcholine receptor expression along with neuromuscular contact size in vitro
35. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation
36. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily
37. Activation state of platelets in experimental severe hemophilia A
38. A031 Développement d’un peptido-mimétique de la glycorpotein VI plaquettaire comme outil d’imagerie de la fibrose
39. A001 Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets
40. A034 Effet anticoagulant et antithrombotique de la PN-1 plaquettaire
41. We-P11:202 Complementary roles of collagen and tissue factor of atherosclerotic lesions in shear-induced thrombus formation via platelet glycoprotein VI
42. Glycoprotein Ib-mediated platelet activation: a signaling pathway evoked by thrombin
43. Binding of Heparin to Platelet Membrane Glycoprotein Ib: Functional Effects
44. Convulxin-induced platelet adhesion and aggregation: involvement of glycoproteins VI and IaIIa
45. Bolhrojaracin, a new type of thrombin inhibitor from snake venom
46. Bothrojaracin: A potent bivalent thrombin inhibitor
47. Thrombin interaction with a recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system
48. An autoantibody directed against human thrombin anion-binding exosite in a patient with arterial thrombosis: effects on platelets, endothelial cells, and protein C activation
49. Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity
50. Effect of phosphopyridoxylation on thrombin interaction with platelet glycoprotein Ib
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.